OP71 Treatment Patterns, Health Resource Utilization, And Costs Of Patients With Diffuse Large B-Cell Lymphoma: A Real-World Analysis
Jorge Daza, Virginia Abello, Natalia Sánchez, Jorge Ceballos, Paola Omaña, Carlos Gómez, Daniel Samacá, Andrés F. Cardona, Sergio Beltran · 2025
Read OP71 Treatment Patterns, Health Resource Utilization, And Costs Of Patients With Diffuse Large B-Cell Lymphoma: A Real-World Analysis by Jorge Daza, Virginia Abello, Natalia Sánchez, Jorge Ceballos, Paola Omaña, Carlos Gómez, Daniel Samacá, Andrés F. Cardona, Sergio Beltran (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768691.txt.
Description
Jorge Daza and co-authors cost out lymphoma care in Colombia in a 2025 conference paper. Diffuse large B-cell lymphoma is the commonest blood cancer in adults there, yet its economic footprint was unmeasured. One cancer center's records met its insurer's billing data.
Sixty-two patients treated from 2022 onward entered this interim cut. Mean age was sixty-six, and men were the majority. A standard risk index spread them across the bands, with the largest group at high-intermediate risk. Regression asked how that risk score moves total cost, adjusting for sex, other illnesses, and cancer history. Drug, procedure, and supply costs all counted. The analysis speaks to planners weighing coverage.
Catalog record
| CREATOR | Jorge Daza, Virginia Abello, Natalia Sánchez, Jorge Ceballos, Paola Omaña, Carlos Gómez, Daniel Samacá, Andrés F. Cardona, Sergio Beltran |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |